A $150 million settlement has been approved in the class action lawsuit filed on behalf of investors who bought the company's common stock in 2000 and 2001. The suit alleged that the company had improperly booked $1.5 billion in revenue in 2000 and 2001 by coaxing wholesalers to buy more of its drugs than they could sell. (Sep-02-04)
Stay Informed
Get the latest on class action lawsuits, settlements & more! Subscribe to our free weekly newsletter.
Get our Newsletter!
Submit a New Complaint
Been wronged by a similar product or service?
Click here to send us your complaint.
